Scientists at the Breast Cancer Now Toby Robins Research Centre at the Institute of Cancer Research, London have identified a new group of people who may benefit from PARP inhibitors.
Leading a healthy lifestyle after a breast cancer diagnosis and treatment can help with this. So, our researchers are looking at ways to better support women with this.
Ductal Carcinoma in Situ (DCIS) is an early form of breast cancer. With DCIS, cancer cells are present in the breast duct, but they can’t spread to the surrounding breast tissue.